Project Details
Description
Bayer 20414: A multicenter, non-randomized, open-label, multiple dose escalation study to evaluate the safety and tolerability of subcutaneous BAY 1093884 in males with hemophilia
| Status | Finished |
|---|---|
| Effective start/end date | 3/11/19 → 3/30/24 |
Funding
- BAYER HEALTHCARE PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.